Reach Us
Niir Project Consultancy Services (NPCS)
AN ISO 9001 : 2015 CERTIFIED COMPANY
106-E, Kamla Nagar,Opposite Spark Mall,
New Delhi-110007, India.
Email: npcs.ei@gmail.com,
info@entrepreneurindia.co
Tel: 91-11-23843955, 23845654, 23845886, +91-8800733955
Mobile: +91-9811043595
Fax: 91-11-23845886
Web: www.entrepreneurindia.co
  • Join Us On
Reach Us
Quick Enquiry
 
   
   
Quick Enquiry
Add to wishlist Add to cart Add to inquiry Buy now Download page as pdf

Asia-Pacific Conjugate Vaccine Market (2018-2023) ( ) ( )

Author Netscribes ISBN -
Code ENI418 Format CD-Rom
Price: Rs 187425   187425 + Tax @ 18.00 % US$ 2499   2499
Pages: 90 Published 2018
Publisher Netscribes  
Usually Ships within 5

"Asia-Pacific Conjugate Vaccine Market:


Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein to enhance immunogenicity and protect against invasive diseases. Asia Pacific is the fastest growing market for conjugate vaccines. The conjugate vaccines market in Asia-Pacific is expected to expand at a CAGR of 23.5%, leading to a revenue of USD 66.61 Bn by 2023. By volume, it is anticipated to reach 6,883.55 Million units by 2023, expanding at a CAGR of 21.87%.


A penetration rate of around 95% of DTP conjugate vaccines indicates an excellent coverage in Asia-Pacific countries and very little is left to achieve full penetration for the vaccines. Countries with high populations such as China and India, serve as major target areas for such vaccines, and the introduction of these vaccines would ensure a disease-free society.


Market Segmentation:


By disease indication, the market is segmented into: 

o Pneumococcal

o Haemophilus influenza type B

o Diphtheria-tetanus-pertussis

o Meningococcal

o Others 


By end user, the market is segmented into: 

o Paediatric

o Adult


By countries, the Asia-Pacific market is divided into: 

o China

o India

o Japan

o South Korea


Key growth factors:


The Asia Pacific has a growing market owing to improvement and advancements in medical science. Awareness about availability of higher number of vaccines as compared to before are major driving factors for the growth of this market. The primary indicators of the potential for the vaccine market are the geriatric population in Asia and its growth in some countries such as India and China. This has encouraged market participants to increase spending on research and development, and distribution facilities in Asian countries.  


Threats and key players:


o The Asia-Pacific Conjugate Vaccine market is expected to grow at a significant rate. But there are issues with regard to health care access and costs. Fragmented health care has a negative impact on the effectiveness of any proposed immunization strategy. Adolescent and adult pertussis is under-recognized by lay and medical communities due to its unique clinical presentation.

o Conjugate Vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.


What’s covered in the report?


1. Overview of the Asia-Pacific conjugate vaccine market

2. Market drivers, and challenges in the Asia-Pacific conjugate vaccine market

3. Market trends in the Asia-Pacific conjugate vaccine market

4. Historical, current and forecasted market size data for the Asia-Pacific based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume

5. Historical, current and forecasted market size data for the Asia-Pacific based on end user (paediatric and adult conjugate vaccines) – by revenue and by volume

6. Historical, current and forecasted market size data of conjugate vaccines of countries (China, India, Japan and South Korea) – by revenue and by volume

7. Historical, current and forecasted market size data for country-wise segments – by revenue and by volume

8. Analysis of the competitive landscape and profiles of major competitors operating in the Asia-Pacific market


Why buy?


o Understand the demand for conjugate vaccines to determine the viability of the market

o Understand the country-specific market size and observations for each segment

o Develop strategies based on the drivers, trends and highlights for each of the segments

o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed

o Recognize the key competitors of this market and respond accordingly

o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction of further growth

o Define the competitive positioning by comparing the products and services with the key players in the market


Customizations available

With the given market data, Netscribes offers customizations according to specific needs. Write to us at support@researchonglobalmarkets.com."

 

 Chapter 1: Executive summary
 1.1 Market scope and segmentation
 1.2 Key questions answered in this study
 1.3 Executive summary - I
 1.4 Executive summary - II

Chapter 2: Market overview
2.1. Market definitions
2.2. Asia-Pacific market overview – by revenue
               - Asia-Pacific historical (2015-2017) market revenue (USD Bn)
  - Asia-Pacific forecasted (2018-2023) market revenue (USD Bn)
  - Country-wise market (2018-2023) revenue (USD Bn)
2.3. Asia-Pacific market overview – by volume
- Asia-Pacific historical (2015-2017) market volume (Million units)
 - Asia-Pacific forecasted (2018-2023) market volume (Million units)
 - Country-wise (2018-2023) market volume (Million units)
2.4. Asia-Pacific market drivers and challenges
2.4.1. Asia-Pacific market drivers
2.4.2. Asia-Pacific market challenges
2.5. Asia-Pacific market trends
2.6. Value chain
2.7.1. Country-specific market overview – China
- Observation
- Key competitors
2.7.1(A) Country-specific market overview – China by revenue and by volume
- China historical (2015-2017) market revenue (USD Bn)
- China forecasted (2018-2023) market revenue (USD Bn)
- China historical (2015-2017) market volume (Million units)
- China forecasted (2018-2023) market volume (Million units)
2.7.2. Country-specific market overview – India
- Observation
- Key competitors
2.7.2(A) Country-specific market overview – India by revenue and by volume
- India historical (2015-2017) market revenue (USD Bn)
- India forecasted (2018-2023) market revenue (USD Bn)
- India historical (2015-2017) market volume (Million units)
- India forecasted (2018-2023) market volume (Million units)
2.7.3. Country-specific market overview – Japan
- Observation
- Key competitors
2.7.3(A) Country-specific market overview – Japan-by revenue and by volume
- Japan historical (2015-2017) market revenue (USD Bn)
- Japan forecasted (2018-2023) market revenue (USD Bn)
- Japan historical (2015-2017) market volume (Million units)
- Japan forecasted (2018-2023) market volume (Million units)
2.7.4. Country-specific market overview – South Korea
- Observation
- Key competitors
2.7.3(A) Country-specific market overview – South Korea-by revenue and by volume
- South Korea historical (2015-2017) market revenue (USD Bn)
- South Korea forecasted (2018-2023) market revenue (USD Bn)
- South Korea historical (2015-2017) market volume (Million units)
- South Korea forecasted (2018-2023) market volume (Million units)

Chapter 3: Asia-Pacific major segment overview - by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal – Asia-Pacific (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Hib – Asia-Pacific (USD Bn, Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP – Asia-Pacific (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Meningococcal – Asia-Pacific (USD Bn, Million units)

Chapter 4: Asia-Pacific major segment overview - by end user
 4.1. End-user: Pediatric, Adult - by revenue, by volume, CAGR
 - Overview - by end user
- Market share (2015, 2018 & 2023): Paediatric – Asia-Pacific (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Adult – Asia-Pacific (USD Bn, Million units)

Chapter 5: China – by disease indication
5.1. China: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.2. China: disease indication - Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.3. China: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.4. China: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways

Chapter 6: China – by end user
6.1. China: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways

Chapter 7: India – by disease indication
7.1. India: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.2. India: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.3. India: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.4. India: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways

Chapter 8: India – by end user
8.1. India: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways

Chapter 9: Japan – by disease indication
9.1. Japan: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.2. Japan: disease indication - Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.3. Japan: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.4. Japan: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways

Chapter 10: Japan – by end user
10.1. China: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways

Chapter 11: South Korea – by disease indication
11.1. South Korea: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.2. South Korea: disease indication - Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.3. South Korea: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.4. South Korea: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways

Chapter 12: South Korea – by end user
12.1. South Korea: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways

Chapter 13: Competitive landscape
13.1. Company market share
- Top 5 companies
13.2. Company overview - GlaxoSmithKline
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.2(A) Executive profile – GlaxoSmithKline
13.3. Company overview – Pfizer Inc.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.3(A) Executive profile - Pfizer Inc.
13.4. Company overview – Merck & Co.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.4(A) Executive profile - Merck & Co.
13.5. Company overview – Novartis
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.5(A) Executive profile - Novartis
13.6. Company overview – Sanofi Pasteur
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.6(A) Executive profile - Sanofi Pasteur
13.7. Company overview – CSL Limited
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.7(A) Executive profile - CSL Limited
13.8. Company overview – Bharat Biotech
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.8(A) Executive profile - Bharat Biotech
13.9. Company overview – Biological E. Limited
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.9(A) Executive profile - Biological E. Limited
13.10. Company overview – Serum Institute of India
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
13.10(A) Executive profile - Serum Institute of India

Appendix
- List of tables
- Assumptions
- Conclusion
-  Research and methodology
-  About Netscribes Inc.

Disclaimer: The Table of Contents (ToC) provided above contains the targeted coverage. The coverage is subject to change as we progress with the research

COMPANIES COVERED
o GlaxoSmithKline
o Pfizer Inc.
o Merck & Co.
o Novartis
o Sanofi Pasteur
o CSL Limited
o Bharat Biotech
o Biological E. Limited
o Serum Institute of India

 

 

ABOUT NPCS

 

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report,  Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Section of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

Our Detailed Project report aims at providing all the critical data required by any entrepreneur vying to venture into Project. While expanding a current business or while venturing into new business, entrepreneurs are often faced with the dilemma of zeroing in on a suitable product/line.

 


And before diversifying/venturing into any product, wish to study the following aspects of the identified product:


• Good Present/Future Demand
• Export-Import Market Potential
• Raw Material & Manpower Availability
• Project Costs and Payback Period


We at NPCS, through our reliable expertise in the project consultancy and market research field, Provides exhaustive information about the project, which satisfies all the above mentioned requirements and has high growth potential in the markets. And through our report we aim to help you make sound and informed business decision.

 

The report contains all the data which will help an entrepreneur find answers to questions like:

• Why I should invest in this project?
• What will drive the growth of the product?
• What are the costs involved?
• What will be the market potential?


The report first focuses on enhancing the basic knowledge of the entrepreneur about the main product, by elucidating details like product definition, its uses and applications, industry segmentation as well as an overall overview of the industry sector in India. The report then helps an entrepreneur identify the target customer group of its product. It further helps in making sound investment decision by listing and then elaborating on factors that will contribute to the growth of product consumption in India and also talks about the foreign trade of the product along with the list of top importing and top exporting countries. Report includes graphical representation and forecasts of key data discussed in the above mentioned segment. It further explicates the growth potential of the product.

The report includes other market data like key players in the Industry segment along with their contact information and recent developments. It includes crucial information like raw material requirements, list of machinery and manufacturing process for the plant. Core project financials like plant capacity, costs involved in setting up of project, working capital requirements, projected revenue and profit are further listed in the report.


Reasons for buying the report:

• This report helps you to identify a profitable project for investing or diversifying into by throwing light to crucial areas like industry size, demand of the product and reasons for investing in the product.

• This report provides vital information on the product like its definition, characteristics and segmentation.

• This report helps you market and place the product correctly by identifying the target customer group of the product.

• This report helps you understand the viability of the project by disclosing details like raw materials required, manufacturing process, project costs and snapshot of other project financials.

• The report provides forecasts of key parameters which helps to anticipate the industry performance and make sound business decision.

 

Our Approach:


• Our research reports broadly cover Indian markets, present analysis, outlook and forecast.

• The market forecasts are developed on the basis of secondary research and are cross-validated through interactions with the industry players. 

• We use reliable sources of information and databases.  And information from such sources is processed by us and included in the report.

 

Our Market Survey cum Detailed Techno Economic Feasibility Report Contains following information:

 

 

Ø  Introduction

·         Project Introduction

·         Project Objective and Strategy

·         Concise History of the Product

·         Properties

·         BIS (Bureau of Indian Standards) Provision & Specification

·         Uses & Applications

 

Ø  Market Study and Assessment

·         Current Indian Market Scenario

·         Present Market Demand and Supply

·         Estimated Future Market Demand and Forecast

·         Statistics of Import & Export

·         Names & Addresses of Existing Units (Present Players)

·         Market Opportunity

 

Ø  Raw Material

·         List of Raw Materials

·         Properties of Raw Materials

·         Prescribed Quality of Raw Materials

·         List of Suppliers and Manufacturers

 

Ø  Personnel (Manpower) Requirements

·         Requirement of Staff & Labor (Skilled and Unskilled) Managerial, Technical, Office Staff and Marketing Personnel

 

Ø  Plant and Machinery

·         List of Plant & Machinery

·         Miscellaneous Items

·         Appliances & Equipments

·         Laboratory Equipments & Accessories

·         Electrification

·         Electric Load & Water

·         Maintenance Cost

·         Sources of Plant & Machinery (Suppliers and Manufacturers)

 

Ø  Manufacturing Process and Formulations

·         Detailed Process of Manufacture with Formulation

·         Packaging Required

·         Process Flow Sheet Diagram

 

Ø  Infrastructure and Utilities

·         Project Location

·         Requirement of Land Area

·         Rates of the Land

·         Built Up Area

·         Construction Schedule

·         Plant Layout and Requirement of Utilities

 

Project at a Glance

Along with financial details as under:

 

  •     Assumptions for Profitability workings

  •    Plant Economics

  •    Production Schedule

  •    Land & Building

            Factory Land & Building

            Site Development Expenses

  •    Plant & Machinery

             Indigenous Machineries

            Other Machineries (Miscellaneous, Laboratory etc.)

  •    Other Fixed Assets

            Furniture & Fixtures

            Pre-operative and Preliminary Expenses

            Technical Knowhow

            Provision of Contingencies

  •   Working Capital Requirement Per Month

             Raw Material

            Packing Material

            Lab & ETP Chemical Cost

           Consumable Store

  •   Overheads Required Per Month And Per Annum

         Utilities & Overheads (Power, Water and Fuel Expenses etc.)

             Royalty and Other Charges

            Selling and Distribution Expenses

  •    Salary and Wages

  •    Turnover Per Annum

  •   Share Capital

            Equity Capital

            Preference Share Capital

 

  •    Annexure 1:: Cost of Project and Means of Finance

  •    Annexure 2::  Profitability and Net Cash Accruals

                Revenue/Income/Realisation

                Expenses/Cost of Products/Services/Items

                Gross Profit

                Financial Charges     

                Total Cost of Sales

                Net Profit After Taxes

                Net Cash Accruals

  •   Annexure 3 :: Assessment of Working Capital requirements

                Current Assets

                Gross Working. Capital

                Current Liabilities

                Net Working Capital

                Working Note for Calculation of Work-in-process

  •    Annexure 4 :: Sources and Disposition of Funds

  •    Annexure 5 :: Projected Balance Sheets

                ROI (Average of Fixed Assets)

                RONW (Average of Share Capital)

                ROI (Average of Total Assets)

  •    Annexure 6 :: Profitability ratios

                D.S.C.R

                Earnings Per Share (EPS)

               

             Debt Equity Ratio

        Annexure 7   :: Break-Even Analysis

                Variable Cost & Expenses

                Semi-Var./Semi-Fixed Exp.

                Profit Volume Ratio (PVR)

                Fixed Expenses / Cost 

                B.E.P

  •   Annexure 8 to 11:: Sensitivity Analysis-Price/Volume

            Resultant N.P.B.T

            Resultant D.S.C.R

   Resultant PV Ratio

   Resultant DER

  Resultant ROI

          Resultant BEP

  •    Annexure 12 :: Shareholding Pattern and Stake Status

        Equity Capital

        Preference Share Capital

  •   Annexure 13 :: Quantitative Details-Output/Sales/Stocks

        Determined Capacity P.A of Products/Services

        Achievable Efficiency/Yield % of Products/Services/Items 

        Net Usable Load/Capacity of Products/Services/Items   

       Expected Sales/ Revenue/ Income of Products/ Services/ Items   

  •    Annexure 14 :: Product wise domestic Sales Realisation

  •    Annexure 15 :: Total Raw Material Cost

  •    Annexure 16 :: Raw Material Cost per unit

  •    Annexure 17 :: Total Lab & ETP Chemical Cost

  •    Annexure 18  :: Consumables, Store etc.,

  •    Annexure 19  :: Packing Material Cost

  •    Annexure 20  :: Packing Material Cost Per Unit

  •    Annexure 21 :: Employees Expenses

  •    Annexure 22 :: Fuel Expenses

  •    Annexure 23 :: Power/Electricity Expenses

  •    Annexure 24 :: Royalty & Other Charges

  •    Annexure 25 :: Repairs & Maintenance Exp.

  •    Annexure 26 :: Other Mfg. Expenses

  •    Annexure 27 :: Administration Expenses

  •    Annexure 28 :: Selling Expenses

  •    Annexure 29 :: Depreciation Charges – as per Books (Total)

  •   Annexure 30   :: Depreciation Charges – as per Books (P & M)

  •   Annexure 31   :: Depreciation Charges - As per IT Act WDV (Total)

  •   Annexure 32   :: Depreciation Charges - As per IT Act WDV (P & M)

  •   Annexure 33   :: Interest and Repayment - Term Loans

  •   Annexure 34   :: Tax on Profits

  •   Annexure 35   ::Projected Pay-Back Period And IRR